Mangoceuticals, Inc. MGRX US Equity
$0.40
+0.00 (+0.50%)
USD · as of 2026-08-28 · marketstack
Mangoceuticals, Inc. (Nasdaq: MGRX), an SEC filer in Services-Misc Health & Allied Services, NEC, closed at $0.40, +0.5%, on 2026-08-28, with a market cap of $9M as of 2026-08-27, a return on equity of -141.6%, a net margin of -4526.8% and 3-year sales growth of 270.9%. Institutional ownership, earnings history and filed financials are on the tabs below.
Short interest· FINRA consolidated · settlement 2026-08-14
6 settlement cycles| Shares short | 1.8M |
| % of shares out | 8.4% |
| Days to cover | 1.0 |
| Δ vs 2026-07-31 | -3.7% |
bars = shares short · line = days to cover (own scale)
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.